Get started
Author

Maike Buchner

Observed names: Buchner, Maike, Buchner, Maike; https://orcid.org/0000-0002-4196-096X, M Buchner, M. Buchner, Maike V Buchner, Maike V. Buchner
Observed institutions: University of Southern California, Children's Hospital of Los Angeles, University of Freiburg, University of California, San Francisco, Maastricht University Medical Centre, University Medical Center Freiburg, TUM Klinikum, Rigel (United States), Deutsches Konsortium für Translationale Krebsforschung, Technical University of Munich
ORCID: 0000-0002-4196-096X
Observed ORCID: 0000-0002-4196-096X
OpenAlex ID: A5081605030
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
2012 · Marcus Dühren-von Minden, Rudolf Übelhart, et al. · Nature · 504
Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
2009 · Maike Buchner, Simon Fuchs, et al. · Cancer Research · 184
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia
2010 · Maike Buchner, Constance Baer, et al. · Blood · 176
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia
2015 · Zhengshan Chen, Seyedmehdi Shojaee, et al. · Nature · 149
PDF
Nanomedicines for the treatment of hematological malignancies
2018 · Anil K. Deshantri, Aida Varela Moreira, et al. · Journal of Controlled Release · 145
PDF
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
2015 · Seyedmehdi Shojaee, Rebecca Caeser, et al. · Cancer Cell · 138
PDF
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
2016 · Seyedmehdi Shojaee, Lai N Chan, et al. · Nature Medicine · 118
Decrypting drug actions and protein modifications by dose- and time-resolved proteomics
2023 · Jana Zecha, Florian P. Bayer, et al. · Science · 117
PDF
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia
2021 · Veronika Ecker, Martina Stumpf, et al. · Nature Communications · 77
PDF
The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice
2011 · Ingo Hilgendorf, Sara Eisele, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 60
Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia
2015 · Maike Buchner, Eugene Park, et al. · Nature Communications · 53
PDF
Foxp1 controls mature B cell survival and the development of follicular and B-1 B cells
2018 · Thomas Patzelt, Selina J. Keppler, et al. · Proceedings of the National Academy of Sciences · 45
PDF
Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels
2012 · F Leonhardt, K Zirlik, et al. · Leukemia · 45
Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia
2010 · Julie Catusse, Marion Leick, et al. · Molecular Cancer · 42
PDF
Targeting the B-cell receptor signaling pathway in B lymphoid malignancies
2014 · Maike Buchner, Markus Müschen · Current Opinion in Hematology · 41
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance
2020 · Eugene Park, Jingyu Chen, et al. · Science Translational Medicine · 40
PDF
Utilizing in vitro drug release assays to predict in vivo drug retention in micelles
2022 · Aida Varela-Moreira, Heleen van Leur, et al. · International Journal of Pharmaceutics · 39
PDF
Mechanisms of pre‐B‐cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia
2014 · Maike Buchner, Srividya Swaminathan, et al. · Immunological Reviews · 39
The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia – CXCR4 antagonists as potential adjuvants for monoclonal antibodies
2010 · Maike Buchner, Philipp Brantner, et al. · British Journal of Haematology · 31
Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer
2021 · Teresa Sadras, Mickaël Martin, et al. · Molecular Cell · 30
PDF
Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression
2023 · Veronika Ecker, Lisa Brandmeier, et al. · Cell Reports · 23
PDF
Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans
2010 · Peter Stachon, Anna Missiou, et al. · PLoS ONE · 23
PDF
Pathological RANK signaling in B cells drives autoimmunity and chronic lymphocytic leukemia
2020 · Begüm Alankus, Veronika Ecker, et al. · The Journal of Experimental Medicine · 20
PDF
Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia
2016 · Marco Benkisser-Petersen, Maike Buchner, et al. · PLoS ONE · 17
PDF
Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells
2010 · Max Warncke, Maike Buchner, et al. · Cancer Immunology Immunotherapy · 15
PDF
Works count: 79
Citation count: 2,248
H-index: 22
I10-index: 29
Year
Topic
Type